Nuntius Therapeutics
Cell-specific genetic medicines
Nuntius Therapeutics is classified as Healthcare from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Nuntius Therapeutics
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
Nanograb
match 33Nanograb is a computational drug discovery company that uses AI to create novel targeted non-viral gene therapy vectors. Our platform designs unique combinations of small peptide binders attached to nanoparticles to safely deliver genetic medicines to specific cells and tissues in the body at scale.
shared product terms: cell, specific, genetic, medicine; shared affiliation: Y Combinator
Silene Biotech
match 19Building your personalized medicine platform using your own cells.
shared product terms: cell, medicine; same category: Healthcare
Engage Bio
match 17Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine. In 2026 Engage was acquired by Eli Lilly.
shared product terms: genetic, medicine; shared affiliation: Y Combinator
Omada Health
match 7Healthcare company.
same category: Healthcare; shared terms: healthcare